Use of obesity drugs in Britain is up eightfold in the last seven years, to more than 1 million prescriptions; the two most popular weight-loss drugs there are orlistat (sold as Xenical by Roche) and sibutramine (sold as Reductil by Abbott Laboratories). Report | Report